Medtronic (MDT) EVP reports RSU tax withholding and holds 34,177 shares

Rhea-AI Filing Summary

Medtronic plc executive reports routine tax-related share withholding. The EVP & President Cardiovascular of Medtronic plc reported a transaction dated 12/05/2025 involving 1,702 ordinary shares of Medtronic. The shares were withheld to cover taxes upon the vesting of previously granted restricted stock units, a common administrative step when equity awards vest. The transaction price listed was $101.36 per share.

After this withholding, the executive beneficially owns 34,177 Medtronic ordinary shares in direct form, which includes 264 shares acquired through dividend reinvestment since the prior report. No derivative securities transactions were reported in this filing.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider KIIL HARRY SKIP

Role EVP & President Cardiovascular

Type	Security	Shares	Price	Value
Tax Withholding	Ordinary Shares	1,702	$101.36	$173K

Holdings After Transaction: Ordinary Shares — 34,177 shares (Direct)

Footnotes (1)

1. Represents shares withheld for taxes upon the vesting of restricted stock units previously reported on Table I. Includes 264 shares acquired through dividend reinvestment since the last report filed by the reporting person.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KIIL HARRY SKIP

(Last) (First) (Middle)

710 MEDTRONIC PARKWAY

(Street)

MINNEAPOLIS MN 55432

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Medtronic plc [ MDT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & President Cardiovascular

3. Date of Earliest Transaction (Month/Day/Year)
12/05/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	12/05/2025		F		1,702(1)	D	$101.36	34,177(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares withheld for taxes upon the vesting of restricted stock units previously reported on Table I.

2. Includes 264 shares acquired through dividend reinvestment since the last report filed by the reporting person.

Remarks:

	/s/ Patricia Walesiewicz, attorney-in-fact	12/09/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Medtronic (MDT) report in this Form 4?

The EVP & President Cardiovascular of Medtronic plc reported a transaction on 12/05/2025 in which 1,702 ordinary shares were withheld to cover taxes upon the vesting of restricted stock units.

At what price were the Medtronic (MDT) shares withheld for taxes?

The 1,702 ordinary shares of Medtronic were withheld at a transaction price of $101.36 per share in connection with the tax withholding on vested restricted stock units.

How many Medtronic (MDT) shares does the executive own after this transaction?

Following the reported transaction, the executive beneficially owns 34,177 Medtronic ordinary shares in direct form, as stated in the filing.

Does the Medtronic (MDT) Form 4 mention dividend reinvestment shares?

Yes. The filing notes that the total holdings of 34,177 shares include 264 shares that were acquired through dividend reinvestment since the last report filed by the reporting person.

What is the reason for the 1,702 Medtronic (MDT) shares reported in this Form 4?

The 1,702 shares represent shares withheld for taxes upon the vesting of restricted stock units that had been previously disclosed, according to the explanation of responses.

Were any derivative securities reported for the Medtronic (MDT) insider in this filing?

No derivative securities transactions were reported. The section for derivative securities shows no acquired or disposed positions for the reporting person.